Gilbert & Cook, Inc. Biogen Inc. Transaction History

Gilbert & Cook, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $170,334 - $266,422	-786 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $28,128 - $35,627	-101 Reduced 11.39%	786 $237,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $260,343 - $340,457	887 New	887 $313,000
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $234,114 - $262,225	-761 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$281.15 - $329.69 $213,955 - $250,894	761	761 $238,000

1,025

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

Stay updated on Gilbert & Cook, Inc. with notifications on news.